The role of cytogenetic abnormalities in acute myeloid leukemia with NPM1 mutations and no FLT3 internal tandem duplication-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The role of cytogenetic abnormalities in acute myeloid leukemia with NPM1 mutations and no FLT3 internal tandem duplication

Published:2009-11-12 Issue:20 Volume:114 Page:4601-4602
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Micol Jean Baptiste¹,Boissel Nicolas²,Renneville Aline³,Castaigne Sylvie⁴,Gardin Claude⁵,Preudhomme Claude³,Dombret Hervé²

Affiliation:

1. Department of Hematology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France

2. Department of Hematology, Hôpital Saint-Louis, AP-HP, Paris, France

3. Department of Hematology, Centre de Biologie-Pathologie, Centre Hospitalier Régional Universitaire de Lille, Lille, France

4. Department of Hematology, Hôpital André Mignot, Versailles, France

5. Department of Hematology, Avicenne, AP-HP, Bobigny, France

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/114/20/4601/1459222/zh804609004601.pdf

Reference8 articles.

1. AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biological, pathological, immunophenotypic, and prognostic features.;Haferlach;Blood,2009

2. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.;Schlenk;N Engl J Med,2008

3. Randomized comparison of double induction and timed-sequential induction to a “3 + 7” induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study.;Castaigne;Blood,2004

4. Effect of priming with granulocyte-macrophage colony stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group.;Thomas;Leukemia,2007

5. Randomized comparison of standard induction with daunorubicin (DNR) for 3 days vs idarubicin (IDA) for 3 or 4 days in AML patients aged 50 to 70 and of maintenance with interleukin-2: final analysis of the ALFA 9801 study [abstract].;Pautas;Blood,2007

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complex karyotype but not other cytogenetic abnormalities is associated with worse posttransplant survival of patients with nucleophosmin 1‐mutated acute myeloid leukemia: A study from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party;American Journal of Hematology;2024-01-02

2. Cytogenetic abnormalities in NPM1-mutated acute myeloid leukemia;Leukemia & Lymphoma;2022-02-28

3. The Role of Nucleophosmin 1 (NPM1) Mutation in the Diagnosis and Management of Myeloid Neoplasms;Life;2022-01-13

4. Prognostic Factors in AML;Acute Myeloid Leukemia;2021

5. Advances in Diagnosis and Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes;Cancer Treatment and Research;2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3